Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter TNFRSF8 Antikörper

TNFRSF8 Reaktivität: Human FACS, IHC, IF, ELISA, InhA Wirt: Kaninchen Chimeric Ki-4 unconjugated Recombinant Antibody
Produktnummer ABIN5668113
  • Target Alle TNFRSF8 Antikörper anzeigen
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    • 134
    • 31
    • 18
    • 16
    Human
    Wirt
    • 86
    • 63
    • 14
    • 4
    • 1
    Kaninchen
    Klonalität
    • 96
    • 71
    • 1
    Chimeric
    Konjugat
    • 68
    • 14
    • 13
    • 12
    • 7
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Dieser TNFRSF8 Antikörper ist unkonjugiert
    Applikation
    • 101
    • 59
    • 59
    • 44
    • 36
    • 27
    • 26
    • 23
    • 13
    • 7
    • 6
    • 6
    • 6
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA, Inhibition Assay (InhA)
    Spezifität
    The antibody binds to CD30.
    Produktmerkmale

    OriginalSpeciesName: Mouse

    OriginalFormat: IgG1

    Aufreinigung
    Purified antibody.
    Immunogen
    Human CD30.
    Klon
    Ki-4
    Isotyp
    IgG kappa
    Top Product
    Discover our top product TNFRSF8 Primärantikörper
  • Applikationshinweise
    The antibody binds specifically to CD30, a cell membrane protein which belongs to the tumour necrosis factor receptor family. Incubation of CD30 positive L540 cells with Ki-4 antibody completely inhibits release of soluble CD30 (in contrast to Ki-3, Ab00474). CD30 is expressed on activated lymphocytes, and binding by its ligands TRAF2 and TRAF5 results in the activation of NF-kappaB, thereby regulating gene expression. CD30 is also associated with Hodgkin Lymphoma, and its expression acts as a tumour marker. Targeting the CD30 antigen with specific monoclonal antibodies is a possible therapy for Hodgkin's lymphoma.
    Kommentare

    This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS with 0.02 % Proclin 300.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target
    TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
    Andere Bezeichnung
    CD30 (TNFRSF8 Produkte)
    Synonyme
    CD30 antikoerper, D1S166E antikoerper, Ki-1 antikoerper, Cd30 antikoerper, Ki antikoerper, TNFRSF8 antikoerper, TNF receptor superfamily member 8 antikoerper, tumor necrosis factor receptor superfamily, member 8 antikoerper, TNFRSF8 antikoerper, Tnfrsf8 antikoerper
    Hintergrund
    TNFRSF8, Tumor necrosis factor receptor superfamily member 8, CD30L receptor, Ki-1 antigen, Lymphocyte activation antigen CD30
    UniProt
    P28908
Sie sind hier:
Kundenservice